Cryptotanshinone suppresses key onco-proliferative and drug-resistant pathways of chronic myeloid leukemia by targeting STAT5 and STAT3 phosphorylation
Crossref DOI link: https://doi.org/10.1007/s11427-018-9324-y
Published Online: 2018-07-20
Published Print: 2018-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dong, Bowen
Liang, Zirui
Chen, Zhirong
Li, Bin
Zheng, Lingling
Yang, Jianhua
Zhou, Hui
Qu, Lianghu
Text and Data Mining valid from 2018-07-20
Article History
Received: 4 May 2018
Accepted: 31 May 2018
First Online: 20 July 2018